Early Lessons From The REMS Battlefield

March 9, 2015

Generic pharmaceuticals save consumers billions of dollars each year. To be sure, the Generic Pharmaceutical Association estimates that in the past decade alone, generic pharmaceuticals saved the United States health system approximately $1.46 trillion dollars. Considering the enormous cost savings afforded by generic drugs, it comes as no surprise that brand name pharmaceutical companies have historically employed highly aggressive, and in some instances, unlawful tactics to prevent competing generic drugs from entering the market.

All Content © 2003‐2015, Portfolio Media, Inc.

The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.


Kellie Lerner


Co-Chair, Antitrust and Trade Regulation Group;
Pronouns: she/her

Back to Top